Branco Mautner

4.8k total citations · 1 hit paper
28 papers, 3.3k citations indexed

About

Branco Mautner is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Branco Mautner has authored 28 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 8 papers in Internal Medicine and 6 papers in Surgery. Recurrent topics in Branco Mautner's work include Acute Myocardial Infarction Research (12 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Branco Mautner is often cited by papers focused on Acute Myocardial Infarction Research (12 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Branco Mautner collaborates with scholars based in Argentina, United States and Canada. Branco Mautner's co-authors include Carolyn H. McCabe, Marc Cohen, Eugene Braunwald, Peter J. L. M. Bernink, Thomas Horacek, Elliott M. Antman, Ramón Corbalán, David Radley, Enrique Gurfinkel and Gerardo Bozovich and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Branco Mautner

27 papers receiving 3.1k citations

Hit Papers

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI 2000 2026 2008 2017 2000 500 1000 1.5k 2.0k

Peers

Branco Mautner
John E. Blair United States
Sreekanth Vemulapalli United States
Francis Zech Belgium
Michael Koller Switzerland
Kenneth R. McQuaid United States
Rod Stables United Kingdom
Dorothy Adcock United States
Branco Mautner
Citations per year, relative to Branco Mautner Branco Mautner (= 1×) peers Enrique Gurfinkel

Countries citing papers authored by Branco Mautner

Since Specialization
Citations

This map shows the geographic impact of Branco Mautner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Branco Mautner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Branco Mautner more than expected).

Fields of papers citing papers by Branco Mautner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Branco Mautner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Branco Mautner. The network helps show where Branco Mautner may publish in the future.

Co-authorship network of co-authors of Branco Mautner

This figure shows the co-authorship network connecting the top 25 collaborators of Branco Mautner. A scholar is included among the top collaborators of Branco Mautner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Branco Mautner. Branco Mautner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barbeau, Gérald, Kevin J. Beatt, Stefan Janssens, et al.. (2006). Adenoviral fibroblast growth factor-4 gene therapy in patients with stable angina. 12-month results of a double blind randomized multicenter trial. Journal of the American College of Cardiology. 47(4). 3 indexed citations
2.
Gurfinkel, Enrique, Gerardo Bozovich, Omar Dabbous, Branco Mautner, & Frederick A. Anderson. (2005). Socio economic crisis and mortality. Epidemiological testimony of the financial collapse of Argentina. Thrombosis Journal. 3(1). 22–22. 17 indexed citations
3.
Fuente, Ricardo León de la, et al.. (2003). Vacunación antigripal en pacientes con síndromes coronarios agudos: beneficio del tratamiento en diferentes subgrupos. Revista Española de Cardiología. 56(10). 949–954. 7 indexed citations
4.
Gurfinkel, Enrique, Ricardo León de la Fuente, Oscar Méndiz, & Branco Mautner. (2002). Influenza Vaccine Pilot Study in Acute Coronary Syndromes and Planned Percutaneous Coronary Interventions. Circulation. 105(18). 2143–2147. 147 indexed citations
5.
Santopinto, José, Enrique Gurfinkel, Gerardo Bozovich, et al.. (2001). Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin. American Heart Journal. 141(4). 566–572. 37 indexed citations
7.
Gurfinkel, Enrique, et al.. (2000). Low-molecular-weight heparin alone versus a combination of unfractionated heparin and low-molecular-weight heparin. American Heart Journal. 140(1). 13A–18A. 2 indexed citations
8.
Barbagelata, Alejandro, Robert M. Califf, Elena B. Sgarbossa, et al.. (2000). Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial). The American Journal of Cardiology. 86(1). 24–29. 6 indexed citations
9.
Gurfinkel, Enrique, et al.. (1999). Thrombotic Reactant Markers in Non-ST Segment Elevation Acute Coronary Syndromes Treated with Either Enoxaparin (Low Molecular Weight Heparin) or Unfractionated Heparin. Journal of Thrombosis and Thrombolysis. 8(3). 227–232. 5 indexed citations
10.
Gurfinkel, Enrique, et al.. (1999). Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non–Q-wave acute myocardial infarction. The American Journal of Cardiology. 83(4). 515–518. 34 indexed citations
11.
Wainsztein, Néstor & Branco Mautner. (1999). A Bullet in the Heart. Circulation. 100(12). 1361–1361. 8 indexed citations
12.
Gurfinkel, Enrique, et al.. (1998). Rationale for the management of coronary syndromes with low-molecular-weight heparins. The American Journal of Cardiology. 82(5). 15L–18L. 9 indexed citations
13.
Gurfinkel, Enrique, et al.. (1997). Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. The Lancet. 350(9075). 404–407. 411 indexed citations
14.
Gurfinkel, Enrique, et al.. (1995). Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. Journal of the American College of Cardiology. 26(2). 313–318. 224 indexed citations
15.
Gurfinkel, Enrique, et al.. (1995). Time significance of acute thrombotic reactant markers in patients with and without silent myocardial ischemia and overt unstable angina pectoris. The American Journal of Cardiology. 76(3). 121–124. 19 indexed citations
16.
Gurfinkel, Enrique, et al.. (1995). 804-2 Low Molecular Weight Heparin, Regular Heparin or Aspirin to Treat Silent Ischemia in Unstable Angina. Journal of the American College of Cardiology. 25(2). 420A–420A. 1 indexed citations
17.
Gurfinkel, Enrique, Ernesto Duronto, Néstor H. García, et al.. (1994). ST‐segment computerized monitoring before and after angioplasty: Clinical correlation with recurrent angina during the short‐term follow‐up. Clinical Cardiology. 17(8). 433–436. 1 indexed citations
18.
19.
Milei, José, Branco Mautner, Rubén Storino, Julian Sanchez, & Victor J. Ferrans. (1992). Does Changas' disease exist as an undiagnosed form of cardiomyopathy in the United States?. American Heart Journal. 123(6). 1732–1735. 41 indexed citations
20.
Mautner, Branco, et al.. (1973). Wedensky phenomena in left bundle branch. The American Journal of Cardiology. 31(2). 288–288. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026